Inhibitors of RAF kinases
US12312336B2 · kind B2 · utility
0Cited by
7References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 25, 2021 |
| Grant date | May 27, 2025 |
| Priority date | — |
| Expiry date | Mar 17, 2044 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are inhibitors of receptor tyrosine kinase effector, RAF, pharmaceutical compositions comprising said compounds, and methods for using said compounds for the treatment of diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.